Axsome Therapeutics to Present at Upcoming Investor Conferences

World News: . []

NEW YORK Oct 12 2018 GLOBE NEWSWIRE -- Axsome Therapeutics Inc (NASDAQ: AXSM a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system CNS disorders, today announced that Herriot Tabutea...

More news and information about Axsome Therapeutics, Inc.

Published By:

Globe Newswire: 12:00 GMT Friday 12th October 2018

Published: .

Search for other references to "axsome" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us